🇺🇸 FDA
Patent

US 9140698

Modulating bacterial MAM polypeptides in pathogenic disease

granted A61KA61K35/74A61K35/741

Quick answer

US patent 9140698 (Modulating bacterial MAM polypeptides in pathogenic disease) held by The Board of Regents of the University of Texas System expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K35/74, A61K35/741, A61K38/164, A61P